A 14-year-old Thai boy presented because of a history of headache, mandibular swelling, and facial nerve palsy. A microorganism identified as Pythium insidiosum was cultured from the mandibular abscesses. Despite treatment with amphotericin B, iodides, ketoconazole, and surgery, the infection progressed. Magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) of the neck revealed an aneurysm in the external carotid artery. The aneurysm was removed. MRA performed later showed stenosis of the internal carotid artery. Immunotherapy was recommended as a last resort. One hundred microliters of the P. insidiosum vaccine was subcutaneously injected into the patient's left shoulder, and 14 days later a similar dose was administered. Four weeks following the first vaccination, the patient's headache had disappeared, the facial swellings had dramatically diminished, the cervical lymph node had shrunk, and the proximal left internal carotid artery stenosis had significantly improved. One year after the vaccinations, the boy was considered clinically cured.
Infections caused by fungal and parafungal organisms are
The currently available antifungal drugs have had little or no effect on P. insidiosum. Reports of pythiosis insidiosi treatoccurring with increasing frequency in patients with debilitating illnesses such as leukemia and AIDS, as well as those undergoing ments with either amphotericin B or surgery or both have indicated that 60% of the patients ultimately died because of immunosuppressive therapy [1] [2] [3] [4] . Within this group of organisms are the traditional pathogenic fungi and a long list of newly progressive dissemination of the hyphal elements of P. insidiosum into healthy tissue [5, 17, 18] . In cases of arterial invasion recognized emerging opportunistic fungal and parafungal organisms. Among the emerging pathogens is the pathogenic oomyby P. insidiosum in humans, amphotericin B and iodides did not eliminate the infections [14, 18] , whereas in surgery the cete Pythium insidiosum, a fungus-like organism classified in the kingdom Stramenopila, phylum Oomycota [5] (organisms main problem has been in determining how much healthy tissue surrounding the infected areas must be excised [7 -9, 14] . Thus, in the kingdom Stramenopila were formerly classified in the kingdoms Protoctista and Chromista [6] ). Pythiosis insidiosi ocrelapses are common in surgically treated patients, who must also endure the pain and distress of such an invasive traumatic curs in humans and lower animals in the tropical, subtropical, and temperate areas of the world [6] .
procedure. The finding that some of the immunogens of P. insidiosum possessed curative properties when injected into equines with See article on related topic by Shenep, English, et al.
pythiosis insidiosi was unexpected [19, 20] . Since then, the on pages 1388 -93.
vaccine has been used as a therapeutic weapon against infections caused by P. insidiosum in equines [21] ; at least two In lower animals, infections of the cutaneous and subcutaneous different immunogens were reported to have cured equines in tissues, lymphatic vessels, intestines, lungs, and bones have Australia [20] , Costa Rica [19] , and the United States [21] . been found. In humans, occurrences of deadly arteritic infecThese two vaccines used hyphal elements and cultured filtrate tions [7 -9] as well as keratitis [10 -12] and subcutaneous invaantigens (CFAs) of P. insidiosum, respectively [22] . Recently, sions [13 -16] have been recorded. a modified formulation of the CFA vaccine, with a property absent in the original vaccine, was found to cure some cases of chronic equine pythiosis insidiosi [23] . We now report that ache. The illness had begun 16 days before admission, in November 1995. Prior to the onset of symptoms, he had sustained a small skin injury on the posterior portion of his neck while swimming in a flooded area near a rice field. Four days following the skin injury, he developed three acne-like nodules at the injured site. He then was admitted to a local hospital because of a severe headache and soft-tissue swelling at the occiput. The swollen mass returned to normal after 2 days of dexamethasone treatment. However, the patient continued to have severe headaches and developed a left-facial-nerve palsy before admission to the Ramathibodi Hospital. The boy had a history of postsplenectomy b-thalassemia hemoglobin E disease, of 4 years' duration. He had received at least three blood transfusions per year after his operation. Headache, bilateral facial-nerve palsy, and progressively extensive facial cellulitis were recorded on admission. Empirical antibiotic treatment with cefotaxime (100 mg/[kgrd]) and chloramphenicol (75 mg/[kgrd]) were prescribed without success. A CT scan of the head and neck showed diffuse cellulitis. Abscesses in the bilateral retromolar fossa and in both ears cm in diameter), with necrosis-like material within its lumen. Although the abscess and cellulitis subsided, 1 week later Histopathologically, eosinophils, macrophages, CD3 / T-cells, the pain and headache reappeared. Swelling of the left side of and plasma cells were observed in the hematoxylin and eosinthe tongue was also noticed. Saturated potassium iodide (1 stained sections. Hyphal elements of P. insidiosum were deg/mL) was prescribed at a dosage of 3 mL/d, gradually increastected within the lumen and the vessel's wall in silver-stained ing to 9 mL/d. Despite this treatment, no clinical improvement tissue sections (figure 3). was observed. MRI of the head and neck demonstrated softPain and headache disappeared immediately after the surgitissue involvement and regional lymph node enlargement (figcal intervention. Five weeks after surgery, the headache and ure 1). Surgical exploration of the left parapharynx and masseswelling of tissue recurred. MRI and magnetic resonance angiteric space was performed. During this procedure, the left abography (MRA) of the neck revealed the persistence of cervical normal cervical lymph nodes and the abnormal left great and paracervical lymph node enlargement and persistent stenoauricular nerve were removed.
sis of the left internal carotid artery (figure 4). These findings Histopathologic examination of the material showed follicusuggested that P. insidiosum had invaded that artery as well. lar hyperplasia with sinus histiocytosis and granulomatous inSurgical removal of the left internal carotid artery was not flammation. Aseptate hyphal elements of P. insidiosum were recommended. Since amphotericin B, ketoconazole, and ioobserved on silver-stained affected tissue. After failure of treatdides had not proved effective over a 3-month period, chemoment with amphotericin B and iodides, chemotherapy with therapy was discontinued 1 week before vaccination. Surgery ketoconazole (300 mg/d) was initiated. In addition, granuloand two courses of GM-CSF alone had also been ineffective cyte-macrophage colony stimulating factor (GM-CSF) was in controlling the infection; thus, the P. insidiosum vaccine given 5 days immediately after surgical exploration.
(PIV) was suggested as a last-resort treatment. The headache and swelling of the tongue diminished after surgical intervention. Although treatment with ketoconazole and iodides continued, pain and headache reappeared 3 weeks Methods later. A CT angiogram revealed an aneurysm in the left external Vaccine Preparation carotid artery, 1.0 cm above the bifurcation, and stenosis (with irregular walls) of the internal carotid artery (figure 2). A third
The PIV had been used only for experimental purposes in equines and dogs with the disease; thus, consents from the surgical intervention was performed on 1 February 1996 to / 9c5c$$de41
11-19-98 16:30:03 cida UC: CID horses, an inflammatory reaction always developed at the site of vaccination. This inflammatory response not only indicated that the host's immune system was functioning but also predicted that the equine probably would be cured by the vaccine. Anergic horses with proven pythiosis insidiosi never developed such a reaction to the vaccine and did not respond to immunotherapy [19 -22] .
To avoid an excessive immunoresponse in the young boy with P. insidiosum arteritis, several dilutions of the original PIV were tested before the trial started. One hundred microliters of each PIV dilution (1:100 to 1:100,000) was injected as a skin test on his right forearm. A mild inflammatory reaction was observed only with the 1:100 dilution of the PIV. Thus, the undiluted batch of PIV was selected. One hundred microliters of the PIV was subcutaneously injected in the patient's left shoulder.
Results

Clinical Course
Twenty hours after vaccination, a wheal and flare reaction had developed at the injection site. Forty-eight hours postvaccination, the wheal attained its maximum size of 11 cm in diameter. No other side effects occurred except for itching at the vaccination site. The skin reaction disappeared 10 days post-vaccination. Fourteen days after the first dose, the facial and tongue swellings had diminished. The same day, a second dose of vaccine was administered in the patient's right shoulder. Forty-eight hours later, the wheal at the vaccination site had attained a diameter of 8 cm.
Two weeks after the second vaccination, the patient's head- Ramathibodi Hospital Committee, the patient, and his parents were obtained before the vaccination trial was begun. The vaccine used in this case was a modification of the original Mendoza vaccine (patent pending) [23] . In brief, inocula of P. insidiosum strain American Type Culture Collection (ATCC) 558643 were grown in Sabouraud dextrose broth (Difco, Detroit). The hyphal mass was washed twice with sterile distilled water and disrupted by sonication. The resulting supernatant was separated from the pellet and then mixed with the liquid phase containing the exoantigens of P. insidiosum. The mixture was then precipitated. The vaccine was stored at 4ЊC until used. A dose of 100 mL of the 2-mg/mL PIV had been utilized to carotid aneurysm (Gomori's methenamine silver stain; original magnification, 1400 [7, 9] . When a serum specimen taken before vaccination was tested in a new ELISA for P. insidiosum [24] , positive titers of 1:6,400 were recorded.
To monitor the vaccination's progress, sera collected 1, 2, 6, and 12 months post-vaccination were also evaluated with the ELISA. No changes in the ELISA titers were recorded after 1 and 2 months post-vaccination. A decrease in titers from 1:6,400 to 1:800 6 months after vaccination, however, indicated that P. insidiosum may have been eliminated from the infected tissues, a finding that substantiated the clinical data. The titer of antibody to P. insidiosum continued to decrease. Low titers, however, may persist for years, as has been previously reported with regard to equines cured by immunotherapy [25] .
Discussion
The response of our patient to the PIV was remarkable. Aside from the wheal and flare reactions at the site of vaccination, also observed after successful vaccination of equines with the disease, no deleterious side effects developed. Within 4 weeks after immunotherapy, the patient's headaches had disappeared, tissue swelling decreased, and he had gained 4.0 kg. Although we used the fullstrength vaccine (2 mg/mL), the patient tolerated the PIV very well. The spectacular response to the PIV in this case is also supported by the hundreds of equine pythiosis insidiosi cases cured by this remarkable therapeutic vaccine. Thus, the PIV may be used as an alternative therapy for humans with the disease. More cases, how- because the available antifungal drugs have had little or no effect on this emerging disease. Thus, the PIV appears to be an attractive therapeutic choice. To our knowledge, this is the dramatically diminished, and the enlarged cervical lymph node first case of pythiosis insidiosi arteritis in a human treated and had been reduced in size. Four weeks post-vaccination, for the cured by an immunotherapeutic PIV. It is also the first case first time the patient's weight had increased by 4.0 kg. The cured by a vaccine prepared with cellular components derived boy was considered clinically cured 1 year after vaccination from a eukaryotic pathogen. (figure 5). Two years after the first vaccination, the boy was Traditionally, vaccines have been used only for prophylactic still in good physical condition.
purposes. The use of vaccines for the treatment of diseases,
MRI and MRA Findings
even though an old idea, has only recently received attention [26, 27] . The long-held medical dogma that vaccines are only MRI performed 6 weeks after the first vaccination showed a for prevention has been challenged by scientists working todecrease in the thickening of the soft tissue and less soft-tissue ward the development of immunotherapeutic vaccines against enhancement of the left side of his tongue. MRA of the neck viruses [28] , parasites [29] , bacteria [30] , and fungal [31] and revealed significant abatement of the stenosis of the proximal left parafungal pathogens [32] . Despite the impressive data regardinternal carotid artery. Twelve months post-vaccination, MRA ing the PIV and other curative vaccines, however, strong skeptishowed a normal left internal carotid artery ( figure 6) .
cism exists about the use of therapeutic vaccines as weapons that eventually will eliminate the invader. If the immune system had been injected only with a placebo (extract of culture medium used to prepare the PIV) later all died of the disease. fails, the use of drugs is the only avenue to pursue in efforts to save a patient's life. However, the findings generated in These findings suggested that the immunogens of the PIV are specific against P. insidiosum and that upon challenge an imstudies of therapeutic vaccines have indicated that a new line of research is necessary to investigate the mechanism by which munoresponse is mounted against the hyphal elements of P. insidiosum. these therapeutic antigens elicit an immunologic reaction that kills the pathogens in infected tissues.
The mechanisms underlying the response to the PIV are not well understood. However, histopathologic and immunologic The specificity of the PIV to cure cases of equine pythiosis insidiosi has been well established. For instance, when Miller studies of cured equines suggested that cellular immunity could play a major role in the clearance of P. insidiosum from infected [20] and later Mendoza et al. [32] vaccinated equines that had pythiosis insidiosi with Conidiobolus coronatus protein tissues [19, 20, 22, 32] . Those studies have shown that after successful immunotherapy, the eosinophilic inflammatory reacextracts, the horses neither responded to the vaccination nor developed inflammatory reactions at the injection sites. Moretion, typical of this disease, gradually changed to a mononuclear immunoresponse. Numerous macrophages, cytotoxic T over, when horses infected with C. coronatus were vaccinated with the PIV, they did not respond at all to the vaccine. By lymphocytes (CTLs), and plasma cells had replaced the eosinophilic granuloma. The role of humoral immunity in the clearcontrast, when some of the above horses infected with P. insidiosum were injected with the PIV, 57% were cured. A control ance of the hyphae of P. insidiosum from the infected tissues is not clear. However, the data obtained in this case and those group of 24 horses with proven equine pythiosis insidiosi that / 9c5c$$de41
11-19-98 16:30:03 cida UC: CID mania major can induce a switch from a nonprotective immunoresponse (mediated by Th2) to protective Th1 immunity [34] .
In that study the expression of a single protein entirely modified the functional immunoresponse to the intact organism. The investigators further hypothesized that immune intervention, by tolerization protocols, ''may be considered for downregulation of deleterious immune responses and for long protection against infectious diseases.'' The results obtained after vaccination of equines and in the case presented here tend to validate their assumption. It is interesting that both L. major and P. insidiosum are eukaryotic organisms, and they elicited a similar immunoresponse in infected hosts. The dramatic events leading to the cure in this case indicate that manipulation of the immune system with immunogens obtained from pathogens, such as P. insidiosum, is possible and that use of PIV in immunotherapy for pythiosis insidiosi should be considered for humans who have not responded well to the available chemotherapy. It is important to mention that the PIV has been tested in another Thai with arteritic pythiosis insidiosi. Details of this new trial will be published elsewhere.
